{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/soligenix-announces-interim-results-from-the-phase-3-flash2-trial-evaluating-hybryte-in-treatment-of-cutaneous-t-cell-lymphoma-302754503.html", "message": "News view counter 684791 successfully enlarged"}